Show simple item record

dc.contributor.authorO'Connor, Kathleen L.
dc.contributor.authorMercurio, Arthur M.
dc.date2022-08-11T08:08:02.000
dc.date.accessioned2022-08-23T15:39:55Z
dc.date.available2022-08-23T15:39:55Z
dc.date.issued2001-10-19
dc.date.submitted2010-11-12
dc.identifier.citationJ Biol Chem. 2001 Dec 21;276(51):47895-900. Epub 2001 Oct 17. <a href="http://dx.doi.org/10.1074/jbc.M107235200">Link to article on publisher's site</a>
dc.identifier.issn0021-9258 (Linking)
dc.identifier.doi10.1074/jbc.M107235200
dc.identifier.pmid11606581
dc.identifier.urihttp://hdl.handle.net/20.500.14038/26284
dc.description.abstractMembers of the Rho family of small GTPases, such as Rho and Rac, are required for actin cytoskeletal reorganization during the migration of carcinoma cells. Phosphodiesterases are necessary for this migration because they alleviate cAMP-dependent protein kinase (PKA)-mediated inhibition of RhoA (O'Connor, K. L., Shaw, L. M., and Mercurio, A. M. (1998) J. Cell Biol. 143, 1749-1760; O'Connor K. L., Nguyen, B.-K., and Mercurio, A. M. (2000), J. Cell Biol. 148, 253-258). In this study, we report that the migration of breast and squamous carcinoma cells toward either lysophosphatidic acid or epidermal growth factor involves not only phosphodiesterase activity but also cooperative signaling from PKA. Furthermore, we demonstrate that Rac1 activation in response to chemoattractant or beta(1) integrin clustering is regulated by PKA and that Rac1 is required for this migration. Also, we find that beta(1) integrin signaling stimulates the rapid and transient activation of PKA. A novel implication of these findings is that carcinoma cell migration is controlled by cAMP-dependent as well as cAMP inhibitory signaling mechanisms.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=11606581&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1074/jbc.M107235200
dc.subjectAntigens, CD29
dc.subjectBreast Neoplasms
dc.subjectChemotaxis
dc.subjectCyclic AMP-Dependent Protein Kinases
dc.subjectEpidermal Growth Factor
dc.subjectHumans
dc.subjectLysophospholipids
dc.subjectSignal Transduction
dc.subjectTumor Cells, Cultured
dc.subjectrac GTP-Binding Proteins
dc.subjectrhoA GTP-Binding Protein
dc.subjectCancer Biology
dc.subjectNeoplasms
dc.titleProtein kinase A regulates Rac and is required for the growth factor-stimulated migration of carcinoma cells
dc.typeJournal Article
dc.source.journaltitleThe Journal of biological chemistry
dc.source.volume276
dc.source.issue51
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cancerbiology_pp/200
dc.identifier.contextkey1640423
html.description.abstract<p>Members of the Rho family of small GTPases, such as Rho and Rac, are required for actin cytoskeletal reorganization during the migration of carcinoma cells. Phosphodiesterases are necessary for this migration because they alleviate cAMP-dependent protein kinase (PKA)-mediated inhibition of RhoA (O'Connor, K. L., Shaw, L. M., and Mercurio, A. M. (1998) J. Cell Biol. 143, 1749-1760; O'Connor K. L., Nguyen, B.-K., and Mercurio, A. M. (2000), J. Cell Biol. 148, 253-258). In this study, we report that the migration of breast and squamous carcinoma cells toward either lysophosphatidic acid or epidermal growth factor involves not only phosphodiesterase activity but also cooperative signaling from PKA. Furthermore, we demonstrate that Rac1 activation in response to chemoattractant or beta(1) integrin clustering is regulated by PKA and that Rac1 is required for this migration. Also, we find that beta(1) integrin signaling stimulates the rapid and transient activation of PKA. A novel implication of these findings is that carcinoma cell migration is controlled by cAMP-dependent as well as cAMP inhibitory signaling mechanisms.</p>
dc.identifier.submissionpathcancerbiology_pp/200
dc.contributor.departmentDepartment of Cancer Biology
dc.source.pages47895-900


This item appears in the following Collection(s)

Show simple item record